SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-24-032309
Filing Date
2024-02-12
Accepted
2024-02-12 17:29:25
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC14D9C d774685dsc14d9c.htm SC14D9C 18062
2 EX-99.1 d774685dex991.htm EX-99.1 10578
3 EX-99.2 d774685dex992.htm EX-99.2 1900
4 GRAPHIC g774685dsp005.jpg GRAPHIC 202912
  Complete submission text file 0001193125-24-032309.txt   312230
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filed by) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Subject) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-87950 | Film No.: 24621482
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)